| Exosomes: composition, biogenesis and function C Théry, L Zitvogel, S Amigorena Nature Reviews Immunology 2 (8), 569, 2002 | 3134 | 2002 |
| Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy L Apetoh, F Ghiringhelli, A Tesniere, M Obeid, C Ortiz, A Criollo, G Mignot, ... Nature medicine 13 (9), 1050, 2007 | 2225 | 2007 |
| Antigen presentation and T cell stimulation by dendritic cells P Guermonprez, J Valladeau, L Zitvogel, C Théry, S Amigorena Annual review of immunology 20 (1), 621-667, 2002 | 2069 | 2002 |
| Calreticulin exposure dictates the immunogenicity of cancer cell death M Obeid, A Tesniere, F Ghiringhelli, GM Fimia, L Apetoh, JL Perfettini, ... Nature medicine 13 (1), 54, 2007 | 1963 | 2007 |
| Innate or adaptive immunity? The example of natural killer cells E Vivier, DH Raulet, A Moretta, MA Caligiuri, L Zitvogel, LL Lanier, ... science 331 (6013), 44-49, 2011 | 1889 | 2011 |
| Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell derived exosomes L Zitvogel, A Regnault, A Lozier, J Wolfers, C Flament, D Tenza, ... Nature medicine 4 (5), 594, 1998 | 1725 | 1998 |
| Cancer despite immunosurveillance: immunoselection and immunosubversion L Zitvogel, A Tesniere, G Kroemer Nature Reviews Immunology 6 (10), 715, 2006 | 1291 | 2006 |
| Immunogenic cell death in cancer therapy G Kroemer, L Galluzzi, O Kepp, L Zitvogel Annual review of immunology 31, 51-72, 2013 | 1267 | 2013 |
| Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming J Wolfers, A Lozier, G Raposo, A Regnault, C Théry, C Masurier, ... Nature medicine 7 (3), 297, 2001 | 1264 | 2001 |
| Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity JI Mayordomo, T Zorina, WJ Storkus, L Zitvogel, C Celluzzi, LD Falo, ... Nature medicine 1 (12), 1297, 1995 | 1259 | 1995 |
| Dendritic cells directly trigger NK cell functions: Cross-talk relevant in innate anti-tumor immune responses in vivo NC Fernandez, A Lozier, C Flament, P Ricciardi-Castagnoli, D Bellet, ... Nature medicine 5 (4), 405, 1999 | 1192 | 1999 |
| Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β–dependent adaptive immunity against tumors F Ghiringhelli, L Apetoh, A Tesniere, L Aymeric, Y Ma, C Ortiz, ... Nature medicine 15 (10), 1170, 2009 | 1191 | 2009 |
| Immunological aspects of cancer chemotherapy L Zitvogel, L Apetoh, F Ghiringhelli, G Kroemer Nature reviews immunology 8 (1), 59, 2008 | 1191 | 2008 |
| Metronomic cyclophosphamide regimen selectively depletes CD4+ CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients F Ghiringhelli, C Menard, PE Puig, S Ladoire, S Roux, F Martin, E Solary, ... Cancer immunology, immunotherapy 56 (5), 641-648, 2007 | 1072 | 2007 |
| Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines. L Zitvogel, JI Mayordomo, T Tjandrawan, AB DeLeo, MR Clarke, MT Lotze, ... Journal of Experimental Medicine 183 (1), 87-97, 1996 | 1066 | 1996 |
| Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota M Vétizou, JM Pitt, R Daillère, P Lepage, N Waldschmitt, C Flament, ... Science 350 (6264), 1079-1084, 2015 | 1059 | 2015 |
| Molecular characterization of dendritic cell-derived exosomes: selective accumulation of the heat shock protein hsc73 C Théry, A Regnault, J Garin, J Wolfers, L Zitvogel, P Ricciardi-Castagnoli, ... The Journal of cell biology 147 (3), 599-610, 1999 | 980 | 1999 |
| Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death N Casares, MO Pequignot, A Tesniere, F Ghiringhelli, S Roux, N Chaput, ... Journal of Experimental Medicine 202 (12), 1691-1701, 2005 | 891 | 2005 |
| CD4+ CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor–β–dependent manner F Ghiringhelli, C Ménard, M Terme, C Flament, J Taieb, N Chaput, ... Journal of Experimental Medicine 202 (8), 1075-1085, 2005 | 888 | 2005 |
| Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors B Routy, E Le Chatelier, L Derosa, CPM Duong, MT Alou, R Daillère, ... Science 359 (6371), 91-97, 2018 | 827 | 2018 |
